Inspirational Women Leaders of Tech: Maria Zannes of bioAffinity Technologies On The Five Things You Need To Know In Order To Create A Very Successful Tech Company

PUBLISHED ON September 26, 2020

Authority Magazine (September 26, 2020) Follow the science. Businesspeople rightfully seek to control a situation, but that does not bode well in the science field. Mother nature has a way of surprising you. Innovation is essential to a biotech company, but it does not reveal itself if you have a limited view of a successful result.

read more

Precision Pathology Services and bioAffinity Technologies Announce Initiation of CLIA Validation for Non-Invasive Early Lung Cancer Test

PUBLISHED ON August 12, 2020

AUGUST 12, 2020 (San Antonio, TX) bioAffinity Technologies, a privately held biotech company advancing cutting-edge cancer diagnostics, and Precision Pathology Services, a CAP/CLIA-certified anatomic and clinical pathology laboratory, announced the initiation of CLIA validation for CyPath® Lung, a non-invasive flow cytometric test for early-stage lung cancer.  Precision Pathology has licensed bioAffinity’s intellectual property for the development of CyPath® Lung as a laboratory-developed test (LDT).

read more

SA Biotech Nearing Launch of Breakthrough Cancer Test

PUBLISHED ON August 11, 2020

San Antonio Business Journal (August 11, 2020) A local pathology practice has initiated a validation study of San Antonio-based bioAffinity Technologies' CyPath Lung early detection cancer test. The validation study is needed for bioAffinity to commercialize the product, which is its first.

read more

bioAffinity Technologies was selected as one of San Antonio’s Top 2020 Innovators. In this video, you will see Maria Zannes, President and Chief Executive Officer, speak about what drives motivation, innovation and success and kick off San Antonio’s premier annual event celebrating the City’s healthcare and bioscience industry.